This article contains a case report of a 19 month old child with Kawasaki Disease who developed bilateral giant coronary artery aneurysms.peer-reviewe

Chintala, Kavitha

Forbes, T.J.

Reddy, S.V.

English

OAR@UM

A predictive instrument for coronary artery aneurysms in Kawasaki disease. United States Multicenter Kawasaki Disease Study Group.

Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [in

Aortic root dilation in Kawasaki disease.

Assessment of coronary function in children with a history of Kawasaki disease using (15)O-water positron emission tomography.

Cardiac transplantation for Kawasaki disease.

Cardiovascular involvement in Kawaski Disease. Images Paediatr Cardiol.

Correlates of coronary artery aneurysm formation in patients with Kawasaki disease.

Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial.

Corticosteroids in the treatment of the acute phase of Kawasaki disease.

Diagnosis and therapy of Kawasaki disease in children.

Does Abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?

Endothelial dysfunction late after Kawasaki disease.

Gallium-67 myocardial imaging for the detection of myocarditis in the acute phase of Kawasaki disease (mucocutaneous lymph node syndrome): the usefulness of single photon emission computed tomography.

Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease. Pediatr Int.

Guidelines for long-term management of patients with Kawasaki disease.

Guidelines for treatment and management of cardiovascular sequelae in Kawasaki disease. Subcommittee of Cardiovascular Sequelae, Subcommittee of Surgical Treatment, Kawasaki Disease Research Committee. Heart Vessels.

How many echocardiograms are necessary for follow-up evaluation of patients with Kawasaki disease?

Kawasaki disease in families.

Kawasaki disease in parents and children. Acta Paediatr.

Kawasaki disease: effect of treatment on coronary artery involvement.

Kawasaki disease: Review of risk factors for coronary aneurysms.

Kawasaki syndrome hospitalizations in the United States,

Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.

Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases.

Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions.

Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease.

Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose.

The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.

Treatment, and Long-Term Management of Kawasaki Disease: A Statement for

Cardiovascular involvement in Kawaski Disease

https://www.um.edu.mt/library/oar/bitstream/handle/123456789/4062/Cardiovascular%20involvement%20in%20Kawaski%20Disease.pdf?sequence=1&isAllowed=y

Cardiovascular involvement in Kawaski Disease

Abstract

Similar works

Full text

Available Versions

OAR@UM